Bufotalidin

Suppliers

Names

[ CAS No. ]:
465-90-7

[ Name ]:
Bufotalidin

[Synonym ]:
(3S,5S,8R,9S,10S,13R,14S,17R)-3,5,14-trihydroxy-13-methyl-17-(6-oxopyran-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
EINECS 207-368-3
Bufotalidin
Hellebrigenin
Gellebrigenin

Chemical & Physical Properties

[ Density]:
1.419g/cm3

[ Boiling Point ]:
626.3ºC at 760 mmHg

[ Melting Point ]:
175 °C

[ Molecular Formula ]:
C24H32O6

[ Molecular Weight ]:
416.50700

[ Flash Point ]:
215ºC

[ Exact Mass ]:
416.22000

[ PSA ]:
107.97000

[ LogP ]:
2.53580

[ Index of Refraction ]:
1.675

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
EI3175800
CHEMICAL NAME :
5-beta-Bufa-20,22-dienolide, 3-beta,5,14-trihydroxy-19-oxo-
CAS REGISTRY NUMBER :
465-90-7
BEILSTEIN REFERENCE NO. :
0056259
LAST UPDATED :
199709
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C24-H32-O6
MOLECULAR WEIGHT :
416.56
WISWESSER LINE NOTATION :
L E5 B666TJ AVH E1 IQ MQ OQ F- ET6OVJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
77 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PHUZBI Pharmazie in Unserer Zeit. (VCH Pub., Inc., 303 N.W. 12th Ave., Deerfield Beach, FL 33441) V.1- 1972- Volume(issue)/page/year: 13,129,1984
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
1345 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. Volume(issue)/page/year: 252,314,1966
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
514 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APJUA8 Acta Pharmaceutica Jugoslavica. (FDH, Masarykova 2, 41000 Zagreb, Yugoslavia) V.1-41, 1951-1991. Volume(issue)/page/year: 24,179,1974 *** REVIEWS *** TOXICOLOGY REVIEW 85ELDJ "Die Herzwirksamen Glykoside," Baumgarten, G., and W. Forster, Leipzig, Ger. Dem. Rep., VEB Georg Thieme, 1963 Volume(issue)/page/year: -,191,1963

Related Compounds

  • N-ethyl-6-methyl-2-[4-(6-methylpyridazin-3-yl)piperazin-1-yl]pyrimidin-4-amine
  • 5-chloro-N-methyl-N-{1-[2-(2H-1,2,3-triazol-2-yl)ethyl]piperidin-4-yl}pyrimidin-2-amine
  • 3-{4-[(5-Chloropyrimidin-2-yl)(methyl)amino]piperidin-1-yl}pyrazine-2-carbonitrile
  • 3-{4-[(5-Chloropyrimidin-2-yl)(methyl)amino]piperidin-1-yl}pyridine-2-carbonitrile
  • 5-chloro-N-[1-(6-ethyl-5-fluoropyrimidin-4-yl)piperidin-4-yl]-N-methylpyrimidin-2-amine
  • 5-chloro-N-methyl-N-{1-[3-(propan-2-yl)-1,2,4-thiadiazol-5-yl]piperidin-4-yl}pyrimidin-2-amine
  • N-cyclopropyl-4-{3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl}morpholine-2-carboxamide
  • N-cyclopropyl-4-[(2-fluorophenyl)methyl]morpholine-2-carboxamide
  • 3-((1,1,2,2-Tetrafluoroethyl)thio)benzoic acid
  • N-cyclopropyl-4-(1-phenylethyl)morpholine-2-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.